Clinical Trials Browser

Phase 1/2 × OTHER × Clinical Protocols × Clear all

NCT04210492 2025-05-14

Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung